News
AZ grabs pair of EU approvals for top cancer drugs
AstraZeneca is celebrating two approvals for cancer drugs Imfinzi and Enhertu in the EU as it faces increased competition to its top-seller Tagrisso.
News
Uplizna is first drug FDA-cleared for rare disease IgG4-RD
Amgen has bagged a second indication for its B cell-depleting therapy Uplizna after the FDA cleared it for rare inflammatory disease IgG4-RD.
News
Germany will reimburse haemophilia gene therapy Hemgenix
Germany has agreed to reimburse CSL Behring's haemophilia B gene therapy Hemgenix with a 'unique' outcomes-based payment model.
News
Novartis gets FDA nod for second of three IgAN drugs
Novartis has claimed accelerated approval in the US for Vanrafia, one of a trio of drugs it hopes will revolutionise the treatment of IgA nephropathy.
News
Pharma in a spin as it tries to gauge Trump tariffs impact
Pharmaceuticals are exempt from the tariffs revealed by President Donald Trump, for now, but the industry is bracing for what may come next.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
